搜索医学 AI 论文与资源

ICLR 2026 Poster accepted paper at ICLR 2026. Real-world temporal data often consists of multiple signal types recorded at irregular, asynchronous intervals. For instance, in the medical domain, different types of blood tests can be measured at different times and frequencies, resulting in fragmented and unevenly scattered temporal data. Similar issues of irregular sampling occur in other domains, such as the monitoring of large systems using event log files. Effectively learning from such data requires handling sets of temporal sparse and heterogeneous signals. In this work, we propose Super Mixing Additive Networks (SuperMAN), a novel and interpretable-by-design framework for learning directly from such heterogeneous signals, by modeling them as sets of implicit graphs.

ICLR 2026 Poster accepted paper at ICLR 2026. In precision medicine, quantitative multi-omic features, topological context, and textual biological knowledge play vital roles in identifying disease-critical signaling pathways and targets, guiding the discovery of novel therapeutics and effective treatment strategies. Existing pipelines capture only one or two of these—numerical omics ignore topological context, text-centric LLMs lack quantitative grounded reasoning, and graph-only models underuse rich node semantics and the generalization power of LLMs—thereby limiting mechanistic interpretability. Although Process Reward Models (PRMs) aim to guide reasoning in LLMs, they remain limited by coarse step definitions, unreliable intermediate evaluation, and vulnerability to reward hacking with added computational cost. These gaps motivate jointly integrating quantitative multi-omic signals, topological structure with node annotations, and literature-scale text via LLMs, using subgraph reasoning as the principle bridge linking numeric evidence, topological knowledge and language context.

This Nature Portfolio / npj Digital Medicine collection is open for submissions until 2027-04-30. It invites work at the intersection of computational drug repurposing, multimodal biomedical data, and AI, including omics, EHRs, real-world evidence, imaging, digital phenotyping, LLMs, graph neural networks, multimodal transformers, knowledge graphs, generative AI, causal inference, explainability, and clinical translation.